A pilot study published today in Communications Medicine demonstrates the potential of a new approach to treating anorexia ...

Across 76 weeks in obesity/overweight without type 2 diabetes, survodutide achieved up to 16.6% mean weight loss versus 3.2% ...

Researchers restored NMDA receptor function by targeting SLC6A20 in autism models. In animal studies, the treatment improved ...

For the first time, dog owners have access to a dental product that reaches every surface in a dog's mouth, stays there long enough to work and has the clinical results to prove it.

News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to ...

The power of Rome was attended with some beneficial consequences to mankind; and the same freedom of intercourse which ...

Malawi’s Judiciary faces scrutiny as Lawyer condemns "injunction culture", political interference - The Maravi Post ...

Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat ...

Fox Sports reporter Erin Andrews drew online scrutiny after posting a Bahamas vacation photo featuring Rams quarterback Matthew Stafford, his wife Kelly, FOX colleague Charissa Thompson, and her ...

Researchers have identified a promising new therapeutic strategy for autism spectrum disorder (ASD). A research team led by ...

A new study reveals that targeting the SLC6A20 glycine transporter with ASOs restores NMDAR function and reverses adult autism behaviors.